Lumanity

Therapeutic Science and Strategy

Science EN ↓ 27 episoder

In this podcast series, Joel Sandler, Principal, BioConsulting, Cancer Cell Therapy Lead, sits down with various guests to talk about important topics that impact the pharmaceutical, biotech, and medical device industries.

Forfatter

Lumanity

Kategori

Science

Podkastens nettsted

sites.libsyn.com

Siste episode

9. jul 2026

Hvor kan du lytte?

Podkaster i appen Replaio Radio Kommer snart

Podkaster kommer snart til appen. Installer nå, og bli den første som ser en helt ny tilnærming til podkaster

Last ned på Google Play Installer gratis Android nesten 10 mill. nedlastinger · 4,8 i vurdering iOS snart

Episoder

CAR-T in Solid Tumors: A Cancer Progress Sneak Peek 25.04.2022

In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this second episode, Joel sits down with  Shivani Srivastava, PhD, Assistant Professor Human Biology Division, Fred Hutchinson Cancer Research Center , to explore: Key challenges to addressing solid tumors with cell therapy Recent developments (technology, scientifi...

Not So Rare: Win-wins in Ultra-orphan Diseases 25.02.2022

In this podcast series, Joel Sandler, Principal, Cancer Cell Therapy Lead, sits down to talk about relevant and important content. In this first episode, Joel sits down with Michael Parisi, CEO of Guidemark, and Michael Rice, Vice President, Head of Advanced Therapeutics, to explore: How uncovering NSCLC and SMA genetics led to record-speed options for patients with rare subtypes How the patient a...

Hør på podkasten Therapeutic Science and Strategy i Replaio

Radio og podkaster i én app - gratis og uten registrering. Installer i dag, og ikke gå glipp av lanseringen

Last ned på Google Play

Replaio er ikke podkastutgiver; programnavn, omslag og lyd tilhører opphavspersonene og distribueres via offentlige RSS-feeder.